6-7 October 2022. Paris, France Last October, the Jérôme Lejeune Foundation had the pleasure to co-organise and host in our headquarters in Paris, the 1st International […]
The idea that a disequilibrium between homocysteine catabolism and the production the cysteine underlies some of the alterations observed in Down syndrome (DS) was suggested by […]
Down syndrome (DS), caused by the complete or partial triplication of chromosome 21, presents a great challenge for research, medical care and development of therapies in […]
Significant headway has been made in recent years to understand the causes of intellectual disability in people with Down syndrome, but therapeutic research on this syndrome […]
